Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
OPERATING EXPENSES
Research and development	$ 2,704	$ 655	$ 4,558	$ 990
Selling, general and administrative	3,720	1,023	7,500	2,065
Total operating expenses	6,424	1,678	12,058	3,055
Loss from operations	(6,424)	(1,678)	(12,058)	(3,055)
OTHER (EXPENSE) INCOME
Change in fair value of derivative liability	47	0	80	0
Interest income	11	3	35	7
Interest expense	(691)	0	(1,339)	0
Net other (expense) income	(633)	3	(1,224)	7
Net loss from operations before discontinued operations	(7,057)	(1,675)	(13,282)	(3,048)
Loss from discontinued operations	(46)	(256)	(23)	(385)
Net loss	$ (7,103)	$ (1,931)	$ (13,305)	$ (3,433)
Net loss per share attributed to common stockholders - basic and diluted (in dollars per share)	$ (2.17)	$ (2.19)	$ (4.59)	$ (4.64)
Weighted-average number of shares - basic and diluted (in shares)	3,379,997	881,294	3,002,815	739,618